New Cancer Drugs Enable Immune Cells to Fight Cancer
New technology for cancer immunotherapy developed at Johns Hopkins University School of Medicine. Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGF-beta enhance the efficacy of cancer immunotherapy.
Read More